AngioDynamics

AngioDynamics is a publicly traded medical device company with a mission to improve patient lives by providing innovative, minimally invasive tools for treating peripheral vascular disease and cancer. The company has strategically evolved from a broad vascular access provider into a focused innovator, building a diversified technology portfolio through R&D and acquisitions. Its current strategy centers on commercializing and expanding the clinical evidence for its three core platforms—Auryon, AlphaVac, and NanoKnife—while navigating a competitive landscape and managing the financial and operational challenges of a mid-cap device maker.

A diversified platform of minimally invasive interventional technologies, including the Auryon laser atherectomy system for PAD, the AlphaVac mechanical thrombectomy system for large-vessel clots, and the NanoKnife irreversible electroporation system for tumor ablation.

AngioDynamics faces fierce competition across all segments: in atherectomy from Philips and Boston Scientific; in thrombectomy from Penumbra and Inari Medical; and in tumor ablation from thermal ablation technologies by Medtronic, Boston Scientific, and J&J. Its strategy relies on clinical differentiation within specialized niches.